Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
37–72
Headlines
1634
Sources here
24
Companies here
22
Current section United States Medical Care Facilities news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Aveanna AVAH Q2 Revenue Rises 13.7% to $670.5 Million

Aveanna Healthcare Holdings (AVAH) reported a 13.7% increase in second-quarter 2026 revenue, reaching $670.5 million, with net income rising to $40.3 million. The company also raised its full-year 2026 revenue guidance to over $2.68 billion and adjusted EBITDA guidance to over $365 million. Insider …

AVAH main company
Sharemaestro market context Trend signal active 52 weeks +34.0% AVAH stored weekly price path from 15 Aug 2025 to 7 Aug 2026

DaVita Inc. (DVA) Stock forecasts

Argus has lowered its target price for DaVita Inc. (DVA) to $187.00. DaVita is identified as the largest provider of dialysis services in the United States, holding approximately 35% market share by clinics. The current price of DVA stock is $181.41.

DVA main company
Sharemaestro market context Trend signal active 52 weeks +35.7% DVA stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Why Brookdale Senior Living (BKD) Is Down 10.0% After Swinging To Q2 Profit On Lower Revenue

Brookdale Senior Living (BKD) reported a swing to net profit in Q2 2026 despite lower revenue, with earnings of US$0.10 per share. The company reaffirmed its 2026 adjusted EBITDA outlook and strengthened its balance sheet through refinancing, aiming for sustained profitability despite ongoing revenue …

BKD main company
Sharemaestro market context Trend signal active 52 weeks +94.5% · Next-week setup positive 60.0% BKD stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Should VA-Backed PIVOT Trial on COMP360 in Veterans Require Action From COMPASS Pathways (CMPS) Investors?

COMPASS Pathways announced a collaboration with the U.S. Department of Veterans Affairs on the PIVOT trial, evaluating COMP360 psilocybin for treatment-resistant depression in veterans, including those with PTSD. This initiative strengthens the clinical narrative for COMP360 and expands its data set within a high-need …

CMPS main company
Sharemaestro market context Trend signal active 52 weeks +213.4% · Next-week setup negative 42.9% CMPS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Royal Bank of Canada Purchases 179,418 Shares of Fresenius Medical Care AG & Co. KGaA $FMS

Royal Bank of Canada significantly increased its stake in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) by 479.2% in the first quarter, acquiring 179,418 additional shares. This brings their total holdings to 216,861 shares, valued at approximately $4.9 million. Despite the substantial purchase, …

FMS main company
Sharemaestro market context Trend signal active 52 weeks +0.7% FMS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Guardian Pharmacy Services opens first location in Kentucky

Guardian Pharmacy Services has opened its first Kentucky location, Guardian Pharmacy of Kentucky, in Lexington. This new long-term care pharmacy will serve residents in various care settings across the state. The expansion aims to meet increasing demand for LTC pharmacy services in Kentucky, combining …

GRDN main company
Sharemaestro market context Trend signal active 52 weeks +85.6% GRDN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Sei Investments Co. Acquires 34,925 Shares of AMN Healthcare Services Inc $AMN

Sei Investments Co. significantly increased its stake in AMN Healthcare Services Inc. (NYSE:AMN) by 204.7% in the first quarter, purchasing an additional 34,925 shares. This move is part of a broader trend of institutional investors adjusting their positions in AMN Healthcare, with several firms …

AMN main company
Sharemaestro market context Trend signal active 52 weeks +90.3% AMN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Pediatrix Medical Group, Inc. Stock 12‑Month Price Target Cut to $26, Implies 2% Downside

The average 12-month price target for Pediatrix Medical Group, Inc. (MD) stock has been lowered from $26.17 to $26 by 5 analysts, with a range of $21 to $28 per share. This new target suggests a potential 2% downside from the August 12 closing …

MD main company
Sharemaestro market context Trend signal active 52 weeks +68.8% · Next-week setup negative 44.7% MD stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Is Tenet’s Golden Cross, Higher EPS Guidance and Ambulatory Push Altering The Investment Case For Tenet Healthcare (THC)?

Recently, Tenet Healthcare reported a bullish technical "golden cross" alongside higher earnings estimates, while management raised its 2026 adjusted EPS guidance and outlined further investment in its ambulatory care platform. The company's emphasis on higher-acuity services, expanding outpatient capabilities, and strengthened earnings outlook has …

THC main company
Sharemaestro market context Trend signal started 52 weeks +52.4% · Next-week setup positive 55.5% THC stored weekly price path from 15 Aug 2025 to 7 Aug 2026

5 Revealing Analyst Questions From AMN Healthcare Services’s Q2 Earnings Call

AMN Healthcare Services reported Q2 results that surpassed analyst expectations, driven by strong demand in its Nurse and Allied Solutions segment and effective execution. The article highlights five key analyst questions from the earnings call, covering topics like contingent labor trends, margin assumptions, bill …

AMN main company
Sharemaestro market context Trend signal active 52 weeks +90.3% AMN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

USPH (USPH) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 10:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Christopher ReadingPresident and Chief Operating Officer, East - Eric WilliamsInterim Chief Financial Officer and Senior Vice President of Finance and Accounting - …

USPH main company
Sharemaestro market context Price above Trend Line 52 weeks -4.3% USPH stored weekly price path from 15 Aug 2025 to 7 Aug 2026

The Top 5 Analyst Questions From DaVita’s Q2 Earnings Call

The Top 5 Analyst Questions From DaVita's Q2 Earnings Call DaVita's second quarter results surpassed Wall Street's revenue and adjusted profit expectations, but the market response was notably negative. Management attributed this to a mix of operational and industry-specific challenges, including flat treatment volumes …

DVA mentioned
Sharemaestro market context Trend signal active 52 weeks +35.7% DVA stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY)

The outpatient and specialty care industry showed strong Q2 results, with revenues beating analysts' consensus estimates. Surgery Partners (NASDAQ:SGRY) reported a 2.7% year-on-year revenue increase to $848.9 million, exceeding expectations, but delivered the slowest revenue growth and weakest full-year guidance among its peers. In …

SGRY main company
Sharemaestro market context Trend signal active 52 weeks -31.9% · Next-week setup negative 37.7% SGRY stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Analysts Offer Insights on NA Companies: Rapid7 (RPD) and Concentra Group Holdings Parent, Inc. (CON)

Analysts from BTIG and Wells Fargo have provided insights on Rapid7 (RPD) and Concentra Group Holdings Parent, Inc. (CON). BTIG maintained a Hold rating for Rapid7, while Wells Fargo assigned a Buy rating to Concentra, indicating potential upside. This report summarizes recent analyst actions …

CON mentioned
Sharemaestro market context Trend signal active 52 weeks +48.2% CON stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Chemed Corp (CHE) Stock Forecasts

Argus has lowered its target price for Chemed Corp (CHE) to $564.00, citing the company's business activities of purchasing, operating, and divesting subsidiaries to maximize shareholder value. As of the report date, Chemed Corp's current price is $540.25. The report suggests upgrading to premium …

CHE main company
Sharemaestro market context Trend signal active 52 weeks +24.7% CHE stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Nutex Health Inc (NUTX) Stock Up 3.6% but GF Value Says Overvalued -- GF Score: 75/100

Nutex Health Inc (NUTX) saw its stock rise by 3.6% to $172.46, yet GuruFocus's GF Value assesses it as significantly overvalued with an intrinsic value of $83.34. Despite a strong GF Score of 75/100 indicating above-average fundamentals, its valuation rank is low, and there's …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +74.4% NUTX stored weekly price path from 15 Aug 2025 to 7 Aug 2026

LifeStance Health Group (NASDAQ:LFST) Major Shareholder Tpg Gp A, Llc Sells 13,643,207 Shares

Major shareholder Tpg Gp A, Llc sold over 13.6 million shares of LifeStance Health Group (NASDAQ:LFST) for approximately $144.9 million, reducing their stake by 12.21%. This transaction follows LifeStance's strong quarterly performance, which saw an EPS beat and 26.1% year-over-year revenue growth, pushing the …

LFST main company
Sharemaestro market context Trend signal active 52 weeks +99.3% LFST stored weekly price path from 15 Aug 2025 to 7 Aug 2026

AMN Signals Greater Appetite for Acquisitions

AMN Healthcare Services Inc. plans to increase its acquisition activity as both the staffing market and the company's financial health improve. The company recently spent $3 million on two acquisitions, Jaide Health and Essential Leadership Assessment, and executives believe they are now in a …

AMN main company
Sharemaestro market context Trend signal active 52 weeks +90.3% AMN stored weekly price path from 15 Aug 2025 to 7 Aug 2026

GMR Solutions Inc. Reports Q2 2026 Financial Results in SEC Form 10-Q Filing

GMR Solutions Inc. has filed its Form 10-Q for Q2 2026, disclosing key financial data as of June 30, 2026. The report highlights total assets of $7.43 billion, a reduction in long-term debt to $4.27 billion, and an increase in tax receivable agreement liability. …

GMRS main company
Sharemaestro market context Stored weekly price path 13 weeks -5.9% GMRS stored weekly price path from 15 May 2026 to 7 Aug 2026

EHC6480675 Bond Price and Chart — FINRA:EHC6480675

This article provides details on the EHC6480675 bond, issued by Encompass Health Corporation. It includes key terms such as a 5.88% coupon and a maturity date of June 1, 2034, along with issuer information, sector, industry, and various identifiers. The bond currently shows no …

EHC main company
Sharemaestro market context Trend signal active 52 weeks +4.6% EHC stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Park Dental Q2 2026 adjusted EPS $0.66 beats estimate; announces Village Family acquisition

Park Dental Partners reported Q2 2026 adjusted EPS of $0.66, significantly surpassing estimates, with revenue rising 5.1% year-over-year to $66.2 million. The company has raised its full-year 2026 revenue guidance and announced the acquisition of Village Family DSO, marking its expansion into a fourth …

PARK main company
Sharemaestro market context Trend signal active 36 weeks +59.1% PARK stored weekly price path from 5 Dec 2025 to 7 Aug 2026

Hudson Vegas Investment Spv, L Sells 50,000 Shares of P3 Health Partners (NASDAQ:PIII) Stock

Hudson Vegas Investment Spv, L sold 50,000 shares of P3 Health Partners (NASDAQ:PIII) stock for $824,000, reducing its stake by over 50%. The sale occurred on August 10th at an average price of $16.48 per share. Despite the sale, P3 Health Partners reported better-than-expected …

PIII main company
Sharemaestro market context Trend signal active 52 weeks +70.9% · Next-week setup negative 43.8% PIII stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Universal Health Services Inc. Cl B stock underperforms Wednesday when compared to competitors despite daily gains

Universal Health Services Inc. Cl B (UHS) shares rose 2.21% on Wednesday, closing at $172.45, despite the stock market experiencing a mixed trading session. This gain broke a two-day losing streak for the company. However, the stock underperformed compared to its competitors.

UHS main company
Sharemaestro market context Price below Trend Line 52 weeks -2.3% UHS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

LifeStance CTO Vukasin Paunovich sells $481,674 in stock

LifeStance Health Group's CTO, Vukasin Paunovich, sold 44,394 shares worth $481,674 on August 10, 2026. This sale occurred after the stock surged 147% over the past year, trading 13% higher than the sale price. The company recently reported strong Q2 2026 financial results, exceeding …

LFST main company
Sharemaestro market context Trend signal active 52 weeks +99.3% LFST stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Park Dental Partners Announces Second Quarter 2026 Results

Park Dental Partners reported its second-quarter 2026 financial results, showing a 5.1% increase in revenue to $66.2 million, driven by acquisitions and favorable reimbursement trends. Despite revenue growth, net income decreased significantly to $1.3 million, largely due to higher salaries and benefits associated with …

PARK main company
Sharemaestro market context Trend signal active 36 weeks +59.1% PARK stored weekly price path from 5 Dec 2025 to 7 Aug 2026

P3 Health Partners (PIII) holder Hudson Vegas updates 17.5% stake and recent share sales

Hudson Vegas Investment SPV, LLC has amended its Schedule 13D filing for P3 Health Partners Inc. (PIII), reporting a beneficial ownership of 17.5%, or 829,651 shares, of Class A Common Stock. This update follows a 1-for-50 reverse stock split and includes details of recent …

PIII main company
Sharemaestro market context Trend signal active 52 weeks +70.9% · Next-week setup negative 43.8% PIII stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Hudson Vegas Investment SPV Completely Divests P3 Health Partners Shares

Hudson Vegas Investment SPV, LLC, along with Hudson Vegas Investment Manager, LLC and Daniel Straus, fully divested their direct holdings of P3 Health Partners Inc. (NASDAQ:PIII) Class A Common Stock on August 10, 2026. The sale involved 50,000 shares across three tranches at weighted …

PIII main company
Sharemaestro market context Trend signal active 52 weeks +70.9% · Next-week setup negative 43.8% PIII stored weekly price path from 15 Aug 2025 to 7 Aug 2026

GMR Solutions Inc. Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Reaffirms Full Year 2026 Guidance

GMR Solutions Inc. (NYSE: GMRS) announced its financial results for the second quarter and first half of 2026, reaffirming its full-year 2026 financial guidance. The company reported net revenue of $1,490.3 million for Q2 2026, a 3.3% increase year-over-year, but experienced a net loss …

GMRS main company
Sharemaestro market context Stored weekly price path 13 weeks -5.9% GMRS stored weekly price path from 15 May 2026 to 7 Aug 2026

P3 Health Partners Inc. - Class A Common Stock (NQ: PIII

This page provides news and financial information for P3 Health Partners Inc. (Nasdaq: PIII). It lists a series of press releases from the company, primarily detailing earnings announcements, conference participations, and scheduling of financial results releases extending from August 2026 back to August 2024. …

PIII main company
Sharemaestro market context Trend signal active 52 weeks +70.9% · Next-week setup negative 43.8% PIII stored weekly price path from 15 Aug 2025 to 7 Aug 2026

COMPASS Pathways (CMPS) Q2 2026 Earnings Call Transcript

COMPASS Pathways reported its Q2 2026 earnings, detailing a net loss of $253.8 million, increased G&A expenses, and $433.3 million in cash and cash equivalents expected to fund operations into 2028. The company is on track to submit the final modules of its New …

CMPS main company
Sharemaestro market context Trend signal active 52 weeks +213.4% · Next-week setup negative 42.9% CMPS stored weekly price path from 15 Aug 2025 to 7 Aug 2026

DaVita Inc. stock outperforms competitors on strong trading day

DaVita Inc. (DVA) saw its stock advance by 1.77% to $181.50 on Wednesday, outperforming the mixed market session. This rise ended a two-day losing streak for the company's shares. The S&P 500 Index rose 0.26%, while the Dow Jones Industrial Average fell 0.04%.

DVA main company
Sharemaestro market context Trend signal active 52 weeks +35.7% DVA stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Ensign Investor News: If You Have Suffered Losses in The

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. (NASDAQ: ENSG) following allegations of misleading business information. This investigation stems from a short seller report claiming Ensign's business model relies on inadequate patient care and understaffing, leading to an …

ENSG main company
Sharemaestro market context Price below Trend Line 52 weeks +10.2% · Next-week setup positive 63.7% ENSG stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Aveanna Healthcare Holdings Q2 2026 Earnings Preview

* Aveanna Healthcare Holdings (AVAH [https://seekingalpha.com/symbol/AVAH]) is scheduled to announce Q2 earnings results on Thursday, August 13th, before market open. * The consensus EPS Estimate is $0.17 [https://seekingalpha.com/symbol/AVAH/earnings/estimates] (+1600.0% Y/Y) and the consensus Revenue Estimate is $638.63M (+8.3% Y/Y). * Over the last 2 …

AVAH main company
Sharemaestro market context Trend signal active 52 weeks +34.0% AVAH stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Concentra Group Holdings Parent (CON) Following Earnings And Guidance Lift Through A Valuation Lens

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Concentra Group Holdings Parent (CON) has given investors a cluster of fresh information in August 2026, including second quarter earnings, new full year …

CON main company
Sharemaestro market context Trend signal active 52 weeks +48.2% CON stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context